Teva Pharmaceuticals USA, Inc recalls Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Bl
Recalled April 3, 2024 · FDA recall D-0428-2024 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications · FDA Class II
Units
92,676 cartons
Sold at
USA nationwide.
Description
Failed Dissolution Specifications
Product
Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →